The trial is designed towards addressing the need for an investigation on this new formulation based on encouraging preclinical evidence for the treatment of Covid-19, Mankind Pharma said in a statement. Mankind Pharma on Tuesday said it has collaborated with…
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling
Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can prevent infection by SARS-CoV-2 coronavirus are now enrolling healthy adults at clinical trial sites in the United States. Many of the trial sites and study…
Celularity begins trial of COVID-19 cell therapy
Celularity has received funding to support a phase I/II clinical trial of human placental hematopoietic stem cell-derived natural killer cells (CYNK-001) for the treatment of COVID-19. The company was awarded $750,000 by the California Institute for Regenerative Medicine. The funds…
Romark begins Phase III trial of Covid-19 drug candidate
Biopharmaceutical company Romark has commenced a Phase III trial of its new investigational drug candidate NT-300 (nitazoxanide) for the treatment of mild or moderate Covid-19. The multicentre, randomised, double-blind trial of the NT-300 drug containing nitazoxanide extended-release tablets will involve…
